Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.

Literature DB >> 18837670

Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.

Titus L Daniels¹, Stephen Deppen, Patrick G Arbogast, Marie R Griffin, William Schaffner, Thomas R Talbot.

Abstract

A retrospective, propensity-matched cohort study was conducted to determine the mortality rate in patients with healthcare-associated infection (HAI) due to multidrug-resistant (MDR) Acinetobacter baumannii. The 28-day mortality rate for patients with MDR A. baumannii HAI was not significantly different than that for patients with non-MDR A. baumannii HAI. The median length of hospital stay before diagnosis of HAI was 4.5 days longer for patients with MDR A. baumannii infection than for patients with non-MDR A. baumannii infection (P < .001).

Entities: Disease Species

Mesh：

Year: 2008 PMID： 18837670 DOI： 10.1086/591456

Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN： 0899-823X Impact factor: 3.254

Keyword Cloud
Cited

10 in total

1. Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.

Authors: William F Penwell; Adam B Shapiro; Robert A Giacobbe; Rong-Fang Gu; Ning Gao; Jason Thresher; Robert E McLaughlin; Michael D Huband; Boudewijn L M DeJonge; David E Ehmann; Alita A Miller
Journal: Antimicrob Agents Chemother Date: 2015-01-05 Impact factor: 5.191

Review 2. Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.

Authors: Elisabeth Paramythiotou; Christina Routsi
Journal: World J Crit Care Med Date: 2016-05-04

3. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Authors: C Routsi; M Pratikaki; E Platsouka; C Sotiropoulou; S Nanas; V Markaki; C Vrettou; O Paniara; H Giamarellou; C Roussos
Journal: Infection Date: 2010-03-12 Impact factor: 3.553

Review 4. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease.

Authors: Dubert M Guerrero; Federico Perez; Nicholas G Conger; Joseph S Solomkin; Mark D Adams; Philip N Rather; Robert A Bonomo
Journal: Surg Infect (Larchmt) Date: 2010-02 Impact factor: 2.150

5. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors: Juthamas Inchai; Chaicharn Pothirat; Chaiwat Bumroongkit; Atikun Limsukon; Weerayut Khositsakulchai; Chalerm Liwsrisakun
Journal: J Intensive Care Date: 2015-03-02

6. ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting.

Authors: Ntobeko B A Ntusi; Motasim Badri; Hoosain Khalfey; Andrew Whitelaw; Stephen Oliver; Jenna Piercy; Richard Raine; Ivan Joubert; Keertan Dheda
Journal: PLoS One Date: 2012-12-27 Impact factor: 3.240

7. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.

Authors: Youn Jeong Kim; Sang Il Kim; Kyung-Wook Hong; Yang Ree Kim; Yeon Joon Park; Moon-Won Kang
Journal: J Korean Med Sci Date: 2012-04-25 Impact factor: 2.153